Condition
Acute Obliterating Bronchiolitis
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Clarithromycin
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Phase 3 (1)
Phase 4 (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT00381147Phase 3Completed
Use of Clarithromycin in Mustard-Induced Bronchiolitis
NCT00367419Phase 4Completed
Use of Erythromycin in Mustard-Induced Bronchiolitis
Showing all 2 trials
Research Network
Common Treatments
- Clarithromycin1
- Erythromycin1
Active Sponsors
- Baqiyatallah Medical Sciences University2
Top Investigators
Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
Related Conditions
- Bronchiolitis Obliterans2